Navidea Biopharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results

Mar 11, 2020

Navidea Biopharmaceuticals to Host Fourth Quarter 2019 Earnings Conference Call and Corporate Update

Mar 4, 2020

Navidea Biopharmaceuticals Regains Compliance with NYSE American Continued Listing Standards

Feb 14, 2020

Navidea Biopharmaceuticals Announces $4.2 Million Sale of Ohio Court Judgment and $3.4 Million Equity Raise Representing $7.6 Million in Additional Funding

Feb 14, 2020

Navidea Biopharmaceuticals Obtains Partial Dismissal of Claims in New York

Dec 30, 2019

Navidea Biopharmaceuticals Announces $1.9 Million Private Placement

Dec 6, 2019

Navidea Biopharmaceuticals to Present at the 12th Annual LD Micro Main Event

Dec 5, 2019

Navidea Biopharmaceuticals Wins Summary Judgment in Ohio

Dec 2, 2019

Navidea Biopharmaceuticals to Present at the PCG Spotlight Series Conference

Nov 14, 2019

Navidea Biopharmaceuticals Reports Third Quarter 2019 Financial Results

Nov 7, 2019